| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9310738 | Kidney International | 2005 | 9 Pages |
Abstract
Whereas inhibition of CDKs by CYC202 reduced intrarenal cell proliferation in passive Heymann nephritis it did not aggravate podocyte damage, suggesting that this novel therapeutic approach is safe in renal diseases characterized by podocyte injury.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Maja Milovanceva-Popovska, Uta Kunter, Tammo Ostendorf, Arndt Petermann, Song Rong, Frank Eitner, Dontscho Kerjaschki, Anna Barnett, Jürgen Floege,